Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether metadoxine is effective for improve survival and reduced oxidative stress in patients with severe alcoholic hepatitis.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02161653
Study type Interventional
Source Hospital General de Mexico
Contact
Status Completed
Phase Phase 4
Start date April 2010
Completion date September 2014

See also
  Status Clinical Trial Phase
Recruiting NCT04106518 - Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
Not yet recruiting NCT06155760 - Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis N/A
Completed NCT02808663 - Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis N/A
Completed NCT01820208 - Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis N/A
Withdrawn NCT03087968 - Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 Early Phase 1
Not yet recruiting NCT02485106 - Rifaximin Use in Severe Alcoholic Hepatitis Phase 3
Recruiting NCT03827772 - Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis- Assessment of Impact on Prognosis and Short-term Outcome N/A
Completed NCT01801332 - Intensive Enteral Nutrition and Acute Alcoholic Hepatitis N/A
Recruiting NCT04103840 - Invasive Fungal Infections in Severe Alcohol-associated Hepatitis
Active, not recruiting NCT03091010 - A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis. N/A